These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 9485533

  • 1. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ, Sack RL, Lewy AJ.
    Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
    van der Heijden KB, Smits MG, van Someren EJ, Boudewijn Gunning W.
    J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W, Didden R, Maas AP, Korzilius H, Smits MG, Curfs LM.
    J Intellect Disabil Res; 2010 Jan 01; 54(1):52-9. PubMed ID: 19888921
    [Abstract] [Full Text] [Related]

  • 10. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J.
    Sleep Med; 2006 Jan 01; 7(1):17-24. PubMed ID: 16309958
    [Abstract] [Full Text] [Related]

  • 11. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
    Laakso ML, Lindblom N, Leinonen L, Kaski M.
    Sleep Med; 2007 Apr 01; 8(3):222-39. PubMed ID: 17368097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Melatonin treatment for age-related insomnia.
    Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU.
    J Clin Endocrinol Metab; 2001 Oct 01; 86(10):4727-30. PubMed ID: 11600532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep 01; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 19. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep 01; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 20. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
    Coppola G, Iervolino G, Mastrosimone M, La Torre G, Ruiu F, Pascotto A.
    Brain Dev; 2004 Sep 01; 26(6):373-6. PubMed ID: 15275698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.